Medtronic plc (MDT)
$92.90-0.48%Close
BUYRECOVERY · day 67
Key stats
Short interest · FINRA settlement 2026-07-31
52-week IV11.5%–47.9%
- Market cap
- $118.9B
- Avg volume
- 9.3M
- Beta
- 0.57
- Div yield
- 3.07%
- P/E (TTM)
- 24.77
- IV-%ile
- 96
- IV ATM
- 36.7%
- Short % float
- 1.42%
- Days to cover
- 2.4
- SI change
- -4.8%
- 1W
- +2.54%
- 1M
- +11.65%
- 3M
- +18.19%
- YTD
- -3.28%
- vs SPY 1W
- +3.73%
- vs SPY 1M
- +8.32%
- vs SPY 3M
- +15.80%
- vs SPY YTD
- -15.03%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CPRXBUYCatalyst Pharmaceuticals, Inc.BULLQ 20$31.49+0.00%
- ABUSBUYArbutus Biopharma CorporationRECOVERYQ 13$5.20-0.19%
- GMEDBUYGlobus Medical, Inc.RECOVERYQ 23$84.08-3.26%
- JAZZSELLJazz Pharmaceuticals plcBULLQ 25$254.47+0.07%
- PLXSELLProtalix BioTherapeutics, Inc.RECOVERYQ 4$2.41+1.26%
- OPRXBUYOptimizeRx CorporationRECOVERYQ 10$7.65-0.78%
- TCMDSELLTactile Systems Technology, Inc.CRISISQ 13$23.36-1.93%
- STEBUYSTERIS plcRECOVERYQ 11$237.87-0.03%
- NBIXSELLNeurocrine Biosciences, Inc.BEARQ 17$153.04+0.31%
- DOCSSELLDoximity, Inc.RECOVERYQ 5$25.30-0.12%
- LKFTBUYRECOVERYQ 8$29.04+0.83%
- ELTPSELLElite Pharmaceuticals, Inc.CRISISQ 5$0.29+0.00%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXBUYVertex Pharmaceuticals Incorporated$139.0BBULLQ 23$547.59-0.08%
- BMYBUYBristol-Myers Squibb Company$137.4BBULLQ 6$67.28+0.40%
- SYKSELLStryker Corporation$125.7BRECOVERYQ 24$327.81-0.50%
- CVSSELLCVS Health Corp.$120.1BBEARQ 10$94.11+1.17%
- SNYBUYSanofi$109.7BRECOVERYQ 6$45.69-0.35%
- GSKBUYGSK plc$103.7BRECOVERYQ 6$51.78-1.11%
- MCKBUYMcKesson Corporation$102.3BRECOVERYQ 12$873.79+1.73%
- HCABUYHCA Healthcare, Inc.$92.9BRECOVERYQ 24$429.24+0.28%
- BSXBUYBoston Scientific Corporation$72.8BRECOVERYQ 7$49.01-2.70%
- EWBUYEdwards Lifesciences Corporation$52.1BBULLQ 19$90.50+0.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 39
- VALUE
- 40
- GROWTH
- 68
- GARP
- 14
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC5.9%
REV YoY-
ROE2.3%
EPS YoY-
ROA5.2%
GROSS65
OP18
NET13
[VALUATION]
P/E TTM24.77
P/E FWD-
SECTOR PE22.66
INDUSTRY PE24.61
P/B2.41
P/FCF-
EV/EBITDA14.91
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E56.53
ALTMAN Z-
CURR RATIO2.13
ND/EBITDA-
BETA0.57
